Dizziness clinical trials

Explore recruiting dizziness clinical trials.

Recruiting dizziness studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Dizziness trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

L-Thyroxine for the treatment of acute unilateral vestibulopathy (AUVP): a monocentric, double-blind, placebo-controlled trial (T4U)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A multicenter, double-blinded, randomized, placebo-controlled trial to compare the effectiveness of intratympanic injections methylPREDnisolone versus placebo in the treatment of vertigo attacks in MENière’s disease (PREDMEN trial).

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomized trial on Spinal Anaesthesia vs. General Anaesthesia (SAGA) on recovery after total hip, total knee, and unicompartmental knee arthroplasty

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

MOTHER trial: Efficacy and safety of low-dose intrathecal morphine following planned caesarean section - a randomised, blinded, clinical, controlled, multicentre trial.

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Phase IIa randomized, double-blind, and placebo-controlled multicenter split body trial to determine safety, tolerability, and efficacy of repeated doses of ACOU085 for the prevention of hearing loss in testicular cancer patients receiving cisplatin

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicenter, Two-arm, Double-blind, Double dummy, Parallel-group Study for efficacy and safety evaluation of prolonged release formulation of Betahistine PR 48 mg once daily in comparison with conventional release formulation of Betahistine IR 24 mg, twice daily in treatment of adult patients with Menière's disease

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Dizziness trials by city

Dizziness in Toronto Dizziness in Vancouver Dizziness in Montreal Dizziness in Calgary Dizziness in Edmonton Dizziness in Ottawa Dizziness in Winnipeg Dizziness in Quebec City Dizziness in Hamilton Dizziness in Kitchener Dizziness in London Dizziness in Halifax Dizziness in New York Dizziness in Los Angeles Dizziness in Chicago Dizziness in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease